Colton Thomas
Charged Alpha Stock Encyclopedia
Charged Alpha reviews earnings for each stock in the Russel 1000 every quarter. Each podcast gives thorough analysis, along with an in-depth profile in the beginning of the episode of the company, what they do, how they earn money and what to look for.
Be sure to visit the podcast's website and support the creator: chargedalpha.podbean.com
Author
Colton Thomas
Category
Podcast website
Latest episode
Oct 24, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Mettler-Toledo (MTD): Beat, Raised — and 68% of the Growth Is the Buyback. Is MTD a Buy? 02.08.2026 14:59
Mettler-Toledo International Inc. (MTD) Q2 2026 — Reported after the close on July 30 (calendar Q2 ended June 30, 2026). Net sales $1,027.3M (+4.5% reported, +6% local currency ex a one-time customer tariff refund, +4% organic); adjusted EPS $11.46 vs ~$10.79 expected (+14%); GAAP diluted EPS $11.55 — higher than the adjusted figure; FY26 guidance raised to $47.15-$47.50. The stock rose 2.59% to $...
Skyworks (SWKS): A Beat, a $2B Buyback, a Killed Dividend — and Free Cash Flow Went NEGATIVE 02.08.2026 13:13
Skyworks Solutions, Inc. (SWKS) Q3 FY2026 — Reported after the close July 28 (fiscal Q3 2026 ended July 3; Skyworks' FY ends October 2). Revenue $934.8M (-3.1% YoY) beat ~$920M; non-GAAP EPS $1.08 beat $1.01 but fell 18.8%; GAAP EPS $0.22 vs $0.70. The board KILLED the dividend and authorised a new $2.0B buyback. The stock fell 5.4% on the print and finished July 31 at $62.28. The line nobody prin...
Disc Medicine (IRON): FDA Said No — the Stock Went Back Anyway. Is IRON a Buy? 02.08.2026 14:00
Disc Medicine, Inc. (IRON) Q2 2026 — Reported before the open on July 30 (calendar Q2 ended June 30, 2026). There is no revenue line: R&D $46.9M (+1.3%), SG&A $18.1M (+20.2%), total operating expenses $65.1M, net loss $59.5M vs $55.2M, loss per share $(1.54) vs $(1.58) on 38.69M weighted shares. Cash, equivalents and marketable securities $717.7M, runway guided into 2029. The stock closed...
IQVIA (IQV): Best Bookings Since 2022, Stock +14% — and GAAP Profit Did Not Move. Is IQV a Buy? 02.08.2026 13:17
IQVIA Holdings Inc. (IQV) Q2 2026 — Reported before the open on July 28 (calendar Q2 ended June 30, 2026). Revenue $4,368M (+8.7% YoY, +8.5% cc); adjusted EPS $3.15 vs $3.03 expected (+12.1%); GAAP diluted EPS $1.53 vs $1.54; adjusted EBITDA $994M (+9.2%); R&D Solutions net new bookings $3.15B (+19%, 1.22x book-to-bill); FY26 guidance raised. The stock closed $213.22 on July 27, jumped 13.9% t...
Woodward (WWD): Record Margins, a Raised Guide — and a 14% Drop. Is WWD Stock a Buy? 02.08.2026 8:56
Woodward, Inc. (WWD) Q3 FY2026 — Reported at 4:00pm ET on July 29 (fiscal Q3 ended June 30, 2026). Net sales $1,109.7M (+21% YoY); adjusted EPS $2.52 vs $2.44 expected (+43%); GAAP EPS $2.40; gross margin 31.5% from 27.2%; record segment margins in both businesses; FY26 adjusted EPS guidance raised to $9.30-$9.50. The stock closed $385.42 on July 29, fell 7.6% to $356.28 on July 30, and closed $36...
Impinj (PI): A RECORD Quarter Built on a Once-a-Year Cheque — Is PI Stock a Buy? 02.08.2026 14:12
Impinj, Inc. (PI) Q2 2026 — Reported after the close on July 29 (quarter ended June 30, 2026). Revenue $108.4M (+11% YoY) vs a $103-106M guide; non-GAAP EPS $0.86 vs ~$0.80 (GAAP $0.39); adjusted EBITDA $30.7M; non-GAAP gross margin 60.9% — all records. The stock closed +5.9% at $147.49 on July 30, then $151.36 on July 31. The record is partly a calendar artifact: ~$17.0M of the $108.4M is the ann...
Sonos (SONO): It Beat on EVERY Line — the Stock Fell 18% — Is SONO Stock a Buy? 02.08.2026 13:47
Sonos, Inc. (SONO) Q3 FY2026 — Reported after the close July 29 (quarter ended June 27, 2026). Revenue $375.3M (+8.8%), non-GAAP EPS $0.27 vs ~$(0.02) expected, adjusted EBITDA $44.0M (+24%), GAAP gross margin 50.4% vs non-GAAP 45.5%. The stock had run 19% into the print to $17.52, then fell 17.6% to $14.43 and closed the week at $14.66. GAAP gross margin came in ABOVE non-GAAP — 50.4% vs 45.5% —...
Sanofi (SNY): Sales +18%, Guidance RAISED — the Stock FELL. Is SNY Stock a Buy? 02.08.2026 14:16
Sanofi (SNY) Q2 2026 — Reported before the European open on July 30 (quarter ended June 30, 2026). Q2 net sales EUR 11,597M, +17.8% at constant exchange rates and +16.0% reported. Business EPS EUR 2.09 per ORDINARY share, +33.3% CER. Business operating income EUR 3,291M at a 28.4% margin, up 380bps. Q2 free cash flow EUR 2,670M, +86.8%. And FY2026 guidance was RAISED to around +10% sales growth at...
Madison Air (MAIR): It RAISED Guidance — the Stock Fell 8% — Is MAIR Stock a Buy? 01.08.2026 15:16
Madison Air Solutions Corporation (MAIR) Q2 2026 — Reported the MORNING of July 30 (quarter ended June 30, 2026). Net sales $991.3M (+21.0% GAAP, +14% pro forma, +14.1% organic), adjusted EBITDA $265.8M at a 26.8% margin (DOWN from 27.5%), GAAP EPS $0.15 vs $0.31 adjusted, backlog $2,868.4M (+133.0%). FY26 sales guidance RAISED $75M to $3,825-3,925M while adjusted EBITDA guidance was REAFFIRMED un...
Arxis (ARXS): GAAP Says It LOST Money — the Stock Rose 28% — Is ARXS Stock a Buy? 01.08.2026 15:03
Arxis, Inc. (ARXS) Q2 2026 — Reported AFTER the close on July 29. Revenue $500.7M (+25.0%, 21.0% ORGANIC), adjusted EBITDA $211.5M (+37.6%) at a 42.2% margin, GAAP net LOSS $(4.9)M / EPS $(0.01) vs $0.28 adjusted, FCF $127.3M (+261%), FY26 guidance RAISED 10%. The stock then rose 27.9% in two sessions to an all-time high. Two things nearly every write-up got wrong: the market cap (feeds showing ~$...
Imperial Oil (IMO): Profit DOUBLED on $92 Oil — and the Stock Moved 0.6% — Is IMO Stock a Buy? 01.08.2026 13:13
Imperial Oil Limited (IMO) Q2 2026 — Imperial Oil reported Q2 2026 (quarter ended June 30) before the open on July 31. ALL COMPANY FIGURES ARE IN CANADIAN DOLLARS; the NYSE American quote is in USD. Net income C$2,190M vs C$949M (+130.8%), diluted EPS C$4.52 vs C$1.86, total revenues C$16,062M (+43.0%), free cash flow C$2,234M (+125%). No identified items. The stock closed US$128.80 -> US$129.5...
ICON plc (ICLR): Best Bookings in CRO History — and the Stock Fell 8% — Is ICLR Stock a Buy? 01.08.2026 13:13
ICON plc (ICLR) Q2 2026 — ICON reported Q2 2026 (quarter ended June 30) after the close on July 29. Revenue $2,063.5M (+1.2%, +0.4% cc), adjusted EPS $2.56 vs $3.52 (-27.3%), adjusted EBITDA $327.2M / 15.9% (from 20.5%). Net book-to-bill 1.51x on gross bookings +24.1%. The stock went $178.18 -> $165.53 -> $163.57: about -8.2% in two sessions. The 1.51x book-to-bill was called 'optically a cr...
Neogen (NEOG): Revenue Fell, It Lost Money, and the Stock Jumped 28% — Is NEOG Stock a Buy? 01.08.2026 15:03
Neogen Corporation (NEOG) Q4 FY2026 — Neogen's fiscal year ends May 31, so the July 30 print is Q4 AND full-year FY2026 — not a calendar Q2. Q4 revenue $225.3M was FLAT (-0.1%), GAAP EPS $(0.05), FY26 revenue -2.7% with a net loss. The stock went $9.40 -> $12.04: about +28% in two sessions, a 12-month high. Something did improve: core growth hit 4.3%, Food Safety core 5.8% (best since FY23), ad...
Cameco (CCJ): Earnings Fell 92% and Guidance Went UP — Is CCJ Stock Worth Buying? 01.08.2026 13:20
Cameco Corporation (CCJ) Q2 2026 — Cameco reports in CANADIAN dollars and trades in New York in US dollars. Q2 2026: revenue C$814M (-7%), net earnings C$25M / C$0.06 (-92%), adjusted net earnings C$77M / C$0.18 (-75%), adjusted EBITDA C$391M (-42%). In US dollars that adjusted figure is ~$0.13 on ~US$573M. The stock was quoted up ~4% pre-market near $92, opened $90.63, traded to $91.38, reversed...
Bandwidth (BAND): Revenue +22%, Real Growth +11.8% — The $68M Footnote That Cost 29% In A Day 01.08.2026 15:09
Bandwidth Inc. (BAND) Q2 2026 — Revenue $219.9M vs $180.0M (+22.2%), a BEAT vs ~$217.0M consensus. Non-GAAP EPS $0.37 (−2.6% YoY). Adj. EBITDA $27.8M (+26.9%). FY26 guidance RAISED again — and the stock fell 29.3%. A beat, a raise, and the worst day in company history — and the reason is footnote one. Bandwidth's revenue contains the service AND pass-through messaging surcharges remitted to carrie...
PTC (PTC): Revenue −7%, ARR +9% — The ASC 606 Trap Almost Every Write-Up Missed 01.08.2026 14:00
PTC Inc. (PTC) Q3 FY2026 — Revenue $600.0M vs $643.9M (−7%, −8% cc) — a MISS vs ~$611.6M consensus. Non-GAAP EPS $1.58 vs $1.64 (−4%), a penny ahead. But constant-currency ARR excluding divestitures grew 9.1% to $2.448B, above the 8–9% guide, net new ARR $60M beat, FCF $249M beat — and PTC RAISED FY26 guidance on every line. The stock rose 0.5% the next session to $136.30. Revenue −7%, ARR +9.1%,...
Stryker (SYK): Beat, Raised The Floor, Fell 6.4% — The $375M Cyber Hole Nobody Refilled 01.08.2026 14:37
Stryker Corporation (SYK) Q2 2026 — Net sales $6.589B (+9.4% reported, +9.0% organic). Adjusted EPS $3.69 vs $3.13 (+17.9%) against ~$3.49 expected — a 20c beat. Adjusted operating margin 27.4%, up 170bps. GAAP EPS $3.30, +44.1%. FY26 guidance NARROWED and the low end RAISED: organic 8.3–9.3% (from 8.0–9.5%) and adjusted EPS $14.95–$15.10 (from $14.90–$15.10). And the stock fell 6.4% the next sess...
Fair Isaac (FICO): Mortgage Revenue +97%, Volumes Flat — The 26% Growth Quarter That Fell 17% 01.08.2026 12:44
Fair Isaac Corporation (FICO) Q3 FY2026 — Revenue $674.2M (+25.7%) but ~$692M expected. Non-GAAP EPS $12.18 vs $8.57 (+42.1%) vs ~$11.97 est. GAAP operating margin 53.8% from 48.9%; 62% non-GAAP. Free cash flow $370.3M (+34.1%). Full-year guidance RAISED to $2.53B revenue and $42.43 non-GAAP EPS. And the stock fell 17.0% the next session, to $1,139.54. Fair Isaac beat, raised full-year guidance, p...
Ingram Micro (INGM): A Record Quarter With Negative Free Cash Flow — Why the Beat Cost It 7% 01.08.2026 14:57
Ingram Micro Holding Corporation (INGM) Q2 2026 — Net sales $14,531.1M (+13.6%), above the high end of guidance. Non-GAAP diluted EPS $0.82 vs $0.61 (+34.4%) vs ~$0.74 est. Adjusted EBITDA $355.8M (+21.0%). Adjusted ROIC 8.4% to 10.8%. Dividend raised to $0.086. And adjusted free cash flow was NEGATIVE $527.3M. The stock closed at $28.21, DOWN 7.2%. Ingram Micro beat on every line it guides to — n...
GoDaddy (GDDY): It Beat Earnings and Fell 17% — Now Priced for a Decline That Hasn’t Started 01.08.2026 14:37
GoDaddy Inc. (GDDY) Q2 2026 — Revenue $1,298.0M (+6.6%), top of guidance. Diluted EPS $1.83 vs $1.41 (+30%) vs ~$1.69 est. Operating income $342.5M (+28.6%), a record 26.4% margin. FCF $443.5M, and the ~$1.8B FY26 target reaffirmed. The stock closed at $82.74, DOWN 16.7%. GoDaddy beat, posted a record margin, generated $443.5M of free cash flow and reaffirmed $1.8B — and lost a sixth of its value...
Guardant Health (GH): Revenue +44%, Shield Volume 4x — Why We Still Say AVOID at $162 01.08.2026 9:51
Guardant Health, Inc. (GH) Q2 2026 — Q2 2026 = the three months ended 30 June 2026, reported after the close on 30 July. Revenue $334.98M vs $232.09M (+44.3%) vs ~$314M consensus; non-GAAP loss $0.42/sh vs ~$0.75 expected. Shield revenue $52.9M on ~66,000 tests from $14.8M and ~16,000. FY26 guidance RAISED to $1.34-1.36B. Stock +6.3% to $161.99. Guardant Health grew revenue 44%, quadrupled Shield...
L3Harris (LHX): A Beat, A Raise, A Record $42B Backlog — and the Stock Fell 11% 01.08.2026 14:20
L3Harris Technologies, Inc. (LHX) Q2 2026 — Q2 2026 = the three months ended 3 July 2026, reported AFTER the close on 29 July. Revenue $5,881M vs $5,426M (+8.4%); GAAP diluted EPS $3.13 vs $2.44 (+28%) vs ~$2.80 consensus. Orders $7.3B, book-to-bill 1.2x, record $42B backlog, guidance RAISED. Then management delayed the missile-business IPO to 2027 — and the stock fell 8.6% next session, 11% intra...
Organon (OGN): EPS Falls 15% — Is the $14 Sun Pharma Buyout Worth It? 01.08.2026 13:17
Organon & Co. (OGN) Q2 2026 — Organon released Q2 2026 with its 10-Q on July 31 — no press release, no call, both suspended for the pending Sun Pharma merger. Revenue $1,558M, -2% reported but -5% ex-FX, missing ~$1,566M. Adjusted EPS $0.85, down 15%, missing ~$0.90. Adjusted EBITDA $461M, a 29.6% margin vs 32.7%. The stock closed at $13.55 — exactly unchanged. It didn't move because Organon i...
Tempus AI (TEM): The First GAAP Profit Is a Stock Gain — and the Operating Loss Got BIGGER 01.08.2026 9:51
Tempus AI, Inc. (TEM) Q2 2026 — Q2 2026 = the three months ended 30 June 2026, reported after the close on 30 July. Revenue $382.5M vs $314.6M (+22%): Diagnostics $289.3M (+20%), Data & Applications $93.2M (+28%, Insights +36%). Gross margin 64.4% from 62.0%. But operating expenses grew 25.5% against revenue at 21.6%, so the LOSS FROM OPERATIONS WIDENED to $(75.9)M from $(61.8)M. GAAP net inco...
Exxon Mobil (XOM): Earnings Tripled and the Stock FELL — Is XOM Worth Buying? 01.08.2026 15:10
Exxon Mobil Corporation (XOM) Q2 2026 — Revenue was ~$116.0B against a ~$98.4B consensus. GAAP earnings $14,525M ($3.48/sh) vs $4,183M ($1.00) in Q1; adjusted $14,680M ($3.52) — SHORT of the ~$3.68 estimate. Operating cash flow $23.6B; free cash flow $17,236M in one quarter — more than all of 2025's $23,612M. The stock closed $155.46, down 0.96% from $156.97, after running ~15% in thirty days. Ear...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.